Skip to content

The effects of glucagon-like peptide-1 receptor agonists on gastric emptying after preoperative fasting.

The effects of glucagon-like peptide-1 receptor agonists on gastric emptying after preoperative fasting. - GALACTIC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57391
Enrollment
30
Registered
2025-04-03
Start date
2025-12-08
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delayed stomach emptying gastroparesis

Interventions

None listed

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult patients (>18 years of age) - Using GLP-1 RA, with a treatment duration over 12 weeks. - Undergoing planned, elective surgery under general anaesthesia - Willing and able to provide informed consent, after adherence to standard preoperative fasting times

Exclusion criteria

Exclusion criteria: - Female who is pregnant or breast-feeding - Patients with an indication for rapid sequence induction and intubation (RSII), related to gastric emptying, such as: o A history of gastroparesis, achalasia, or neuromuscular disorders o Gastric outlet obstruction o Hiatus hernia o History of oesophageal cancer or stricture o Previous upper gastrointestinal or bariatric surgery o Ascites o Small bowel obstruction

Design outcomes

Primary

MeasureTime frame
Difference in gastric volume in ml/kg, measured by gastric ultrasound (GU), between preoperative anaesthesiology visit (GU1, while using GLP-1 RA) and before surgery (GU2, after withholding GLP-1 RA). Patients are required to fast before both GU according to the perioperative protocol (6 hours for solids, 2 hours for clear liquids).

Secondary

MeasureTime frame
Difference for the incidence of residual gastric content (RGC), defined as >1.5ml/kg fluids or presence of solids, between GU2 and GU1. Difference in fasting blood glucose concentration comparing GU2 and GU1.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)